Medical device maker Minnetronix touted its acquisition of privately held Neurofluidics, a company developing treatment for neurological disorders. The details of the merger were not disclosed.
California-based Neurofluidics became a subsidiary of Minnetronix, which Minnetronix president & CEO Rich Nazarian called a "natural fit."